James Urbanic, MD
University of California, San Diego · Wake Forest University Health Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Urbanic, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:08 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04062708 · CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung CancerAlliance Foundation Trials, LLC. · active not recruiting · Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer · study chair
- Ph1/Ph2NCT00311597 · Extracranial Stereotactic Radiosurgery in Treating Patients With Solid TumorsWake Forest University Health Sciences · completed · Unspecified Adult Solid Tumor, Protocol Specific · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:08 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 18 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Assertive Case Management and Motivational InterviewingH79TI024339 · SAMHSA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2012 to 2014Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.